Stay updated on Optimal Pembrolizumab and Chemotherapy Sequence in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Optimal Pembrolizumab and Chemotherapy Sequence in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Optimal Pembrolizumab and Chemotherapy Sequence in NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.5%
    Check dated 2025-06-19T19:07:16.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-05T11:04:08.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    0.8%
    Check dated 2025-05-29T05:48:47.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has removed two significant references to studies on non-small cell lung cancer, which may impact the availability of critical information for readers seeking insights on treatment options.
    Difference
    0.3%
    Check dated 2025-05-22T02:17:10.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The page has undergone significant changes with the removal of three important cancer research articles, which were previously cited, and the addition of the same articles without their erratum notes.
    Difference
    0.4%
    Check dated 2025-05-14T20:41:23.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The page has updated the reference for the study on crizotinib versus chemotherapy in advanced ALK-positive lung cancer, removing an erratum note and updating the version number from v2.15.0 to v2.15.2.
    Difference
    0.3%
    Check dated 2025-04-30T13:51:29.000Z thumbnail image

Stay in the know with updates to Optimal Pembrolizumab and Chemotherapy Sequence in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Optimal Pembrolizumab and Chemotherapy Sequence in NSCLC Clinical Trial page.